These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 16950172)

  • 1. Acute coronary syndrome may occur with in-stent restenosis and is associated with adverse outcomes (the PRESTO trial).
    Assali AR; Moustapha A; Sdringola S; Denktas AE; Willerson JT; Holmes DR; Smalling RW
    Am J Cardiol; 2006 Sep; 98(6):729-33. PubMed ID: 16950172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognosis after acute coronary syndrome. Lack of difference according to the sex].
    Bounhoure JP; Farah B; Fajadet J; Marco J
    Bull Acad Natl Med; 2004; 188(3):383-97; discussion 397-9. PubMed ID: 15584651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of in-stent restenosis on death and myocardial infarction.
    Steinberg DH; Pinto Slottow TL; Buch AN; Javaid A; Roy PK; Garg S; Okabe T; Torguson R; Smith KA; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2007 Oct; 100(7):1109-13. PubMed ID: 17884372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of sirolimus-eluting stenting and its effect on restenosis in patients with unstable angina pectoris (a SIRIUS substudy).
    Weisz G; Moses JW; Teirstein PS; Holmes DR; Raizner AE; Satler LF; Mishkel G; Wilensky RL; Wang P; Kuntz RE; Popma JJ; Leon MB
    Am J Cardiol; 2007 Apr; 99(8):1044-50. PubMed ID: 17437725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of drug-eluting stents when inserted for on- and off-label indications.
    Qasim A; Cosgrave J; Latib A; Colombo A
    Am J Cardiol; 2007 Dec; 100(11):1619-24. PubMed ID: 18036358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of acute coronary syndrome on clinical, economic, and cardiac-specific health status after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: 1-year results from the stent or surgery (SoS) trial.
    Zhang Z; Spertus JA; Mahoney EM; Booth J; Nugara F; Stables RH; Weintraub WS
    Am Heart J; 2005 Jul; 150(1):175-81. PubMed ID: 16084166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of in-stent restenosis and patient outcome after percutaneous coronary intervention in patients with diabetes mellitus.
    Sukhija R; Aronow WS; Sureddi R; Aleti S; Molavi B; Sachdeva R; Mehta JL
    Am J Cardiol; 2007 Sep; 100(5):777-80. PubMed ID: 17719319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents.
    Steinberg DH; Gaglia MA; Pinto Slottow TL; Roy P; Bonello L; De Labriolle A; Lemesle G; Torguson R; Kineshige K; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2009 Feb; 103(4):491-5. PubMed ID: 19195508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of serum N-terminal pro-brain natriuretic peptide to predict in-stent restenosis in patients with preserved left ventricular function and normal troponin I levels.
    Hong SN; Ahn Y; Yoon NS; Lee KH; Kim YS; Hwang SH; Lee SR; Kim KH; Park HW; Hong YJ; Kim JH; Jeong MH; Cho JG; Park JC; Kang JC
    Am J Cardiol; 2007 Apr; 99(8):1051-4. PubMed ID: 17437726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bare metal stent restenosis is not a benign clinical entity.
    Chen MS; John JM; Chew DP; Lee DS; Ellis SG; Bhatt DL
    Am Heart J; 2006 Jun; 151(6):1260-4. PubMed ID: 16781233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous coronary intervention with drug-eluting stents in octogenarians: characteristics, clinical presentation, and outcomes.
    Hassani SE; Wolfram RM; Kuchulakanti PK; Xue Z; Gevorkian N; Suddath WO; Satler LF; Kent KM; Pichard AD; Weissman NJ; Waksman R
    Catheter Cardiovasc Interv; 2006 Jul; 68(1):36-43. PubMed ID: 16764007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of results of percutaneous coronary intervention for non-ST-elevation acute myocardial infarction or unstable angina pectoris in men versus women.
    Elkoustaf RA; Mamkin I; Mather JF; Murphy D; Hirst JA; Kiernan FJ; McKay RG
    Am J Cardiol; 2006 Jul; 98(2):182-6. PubMed ID: 16828589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Safety and effectiveness of pharmacologic versus mechanical stabilization of borderline coronary lesions in patients with acute coronary syndromes].
    Legutko J; Dudek D; Chyrchel M; Rzeszutko L; BartuĊ› S; Heba G; Dubiel JS
    Przegl Lek; 2005; 62(1):1-7. PubMed ID: 16053211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation between soluble intercellular adhesion molecule-1, statin therapy, and long-term risk of clinical cardiovascular events in patients with previous acute coronary syndrome (from PROVE IT-TIMI 22).
    Ray KK; Morrow DA; Shui A; Rifai N; Cannon CP
    Am J Cardiol; 2006 Oct; 98(7):861-5. PubMed ID: 16996863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era: a report from the Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial.
    Mathew V; Gersh BJ; Williams BA; Laskey WK; Willerson JT; Tilbury RT; Davis BR; Holmes DR
    Circulation; 2004 Feb; 109(4):476-80. PubMed ID: 14732749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial.
    Patti G; Pasceri V; Colonna G; Miglionico M; Fischetti D; Sardella G; Montinaro A; Di Sciascio G
    J Am Coll Cardiol; 2007 Mar; 49(12):1272-8. PubMed ID: 17394957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up results after plain balloon coronary angioplasty.
    Gambhir DS; Sudha R; Singh S; Kaul UA; Arora R
    Indian Heart J; 1999; 51(4):403-9. PubMed ID: 10547938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of the 2.25-mm sirolimus-eluting Bx Velocity stent in the treatment of patients with de novo native coronary artery lesions: the SIRIUS 2.25 trial.
    Moses JW; Nikolsky E; Mehran R; Cambier PA; Bachinsky WB; Leya F; Kuntz RE; Popma JJ; Schleckser P; Wang H; Cohen SA; Leon MB;
    Am J Cardiol; 2006 Dec; 98(11):1455-60. PubMed ID: 17126649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of patients with prior percutaneous revascularization undergoing repeat coronary intervention (from the PRESTO Trial).
    Arjomand H; Willerson JT; Holmes DR; Bamlet WR; Surabhi SK; Roukoz B; Espinoza A; McClelland RL; McCormick DJ; Goldberg S;
    Am J Cardiol; 2005 Sep; 96(6):741-6. PubMed ID: 16169350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
    Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL;
    Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.